May 9, 2007

 

NeuroScience Insights for Health Care Professionals

 

The physicians and staff of The Neuroscience Group are providing this physician and provider communication to help you stay abreast of issues and updates in the dynamic field of neurosciences, with the goal of helping you provide better overall healthcare services to your patients.

 

Parkinson’s Disease-Dealing with Common Concerns

To Drive or Not-to-Drive

Assessing and counseling patients with Parkinson’s disease (PD) in relation to ability to continue to drive motorized vehicles is a difficult component of patient management.  A recent study has determined that overall driving impairment in PD is associated with advancing disease severity.  However, driving ability seems to be more strongly influenced by age and cognitive dysfunction.  Cognition, especially executive function, needs to be included in the assessment prior to making a determination to allow continued driving.  Computerized cognitive testing is useful in this regard.  The study done by Cubo, et. al demonstrated that in 75% of cases (n=135) age, cognitive dysfunction, followed by levodopa dose and Hoehn-Yahr (HY) stage were the most significant clinical predictors that differentiated drivers from ex-drivers.

Seeking Advice

Patients with Parkinson’s diseases are often looking for ongoing counseling, education and support.  A recent study on telephone healthcare utilization in Parkinson’s patients demonstrated that increased telephone utilization in PD is associated with anxiety, depression and sleep disturbances.  Surprisingly, increased telephone calls to providers were not associated with motor disability.  Anecdotal evidence had suggested that PD patients have higher phone utilization than other patients with similar medical conditions  with similar physical disabilities.  Non-demented PD patients from an outpatient setting were classified into two groups:  high call rate > 1.9 calls/100 days and low call rate < 1.9 calls/100 days.  Frequent callers had a mean rate of 2.42 calls/100 days vs. low rate of .56 calls/100 days.  No statistical differences between the two groups were noted for age, gender, ethnicity, age of onset or duration of disease.    Frequent callers had higher Beck Anxiety Inventory scores, lower quality of life scores on the PDQUALIF and higher prevalence of sleep disorders.  No statistical differences noted in motor disease as measured by the UPDRS.

The conclusions from this study are borne out in our practice, as noted by the high volume of calls our triage nurses receive from patients with  neurodegenerative disease, such as PD.  Kristine Twomey, RN serves as the coordinator for the APDA referral center, hosted by the Neuroscience Group of NE Wisconsin. THE APDA provides many options for patient education and support services for patients with PD and other movement disorders.  Dr. Lisa Kokontis and Ms. Twomey conduct a PD subspecialty clinic weekly.  For more information on PD, contact:

gizell.larson@neurosciencegroup.com  susan.hibbs@neurosciencegroup.com
steven.price@neurosciencegroup.com   lisa.kokontis@neurosciencegroup.com
thomas.mattio@neurosciencegroup.com


 

This email was sent on behalf of The Neuroscience Group by:
Skyline Technologies
1400 Lombardi Ave # 104N Green Bay, WI 54304-3926 USA



Update Profile | One-Click Unsubscribe


 

Services Available:
Fox Cities
Green Bay
New London
Shawano
Waupaca

 


Resources:


Contact Us:

Margie Weiss, PHD, APNP
920-721-1527
margie.weiss@
neurosciencegroup.com

Steven Price, MD
President / Chairman of the Board
920-721-1508
steven.price@
neurosciencegroup.com